LivaNova (LIVN) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 5, 2026

Source: earnings call transcript

LivaNova delivered a strong second quarter, achieving record revenue and EPS, driven by robust performance in its Cardiopulmonary and Epilepsy segments. The company raised its full-year revenue and EPS guidance, reflecting confidence in its operational execution and strategic investments, despite a lowered free cash flow outlook due to increased capital expenditures and a slight delay in the next-gen OSA system submission.

You’re reading a preview. Opening the full call uses 1 concall credit.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.